Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Endogenous tripeptide studied in cellular redox and antioxidant research
Sign up for the Bodywork newsletter.
Most GI events were classified as mild to moderate and occurred during the dose-escalation phase, consistent with the pattern seen across the GLP-1 receptor agonist class [4]
Studies have found GLP-1 receptors in the kidney itself.3 The protective effects include: reducing inflammation in kidney tissue, lowering blood pressure (by about 5-7 mmHg), improving how kidneys filter blood, and reducing protein leakage into urine an early warning sign of kidney damage.4 THE BIGGER PICTURE: 85,000+ PATIENTS A major meta-analysis of 11 clinical trials with 85,373 patients confirmed the kidney benefits
3 Other metabolic imbalances increase the likelihood of treatment resistance by fourfold, thus emphasizing the need for personalized and metabolically informed treatment strategies
Trammell, M.S
